Patent · US Active

Compositions including triciribine and trastuzumab and methods of use thereof

US8623834B2 · kind B2 · utility

1Cited by

22References

17Claims

0Family size

Assignee

University of South Florida · US

Inventors

Jin Q. Cheng · Tampa, US
Said M. Sebti · Tampa, US

Key dates

Filing date	Apr 23, 2012
Grant date	Jan 7, 2014
Priority date	—
Expiry date	Apr 23, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/73
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates to combination therapies including triciribine and related compounds and trastuzumab or a salt thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.